⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13122621 | 0.75 | MAPT (0.31) | — | |
| SCHEMBL14795328 | 0.75 | — | — | |
| SCHEMBL711956 | 0.75 | — | — | |
| SCHEMBL13817429 | 0.73 | — | — | |
| SCHEMBL9072310 | 0.73 | — | — | |
| SCHEMBL3603505 | 0.73 | — | — | |
| SCHEMBL315831 | 0.73 | — | — | |
| SCHEMBL19297916 | 0.72 | — | — | |
| SCHEMBL2798745 | 0.71 | — | — | |
| SCHEMBL5487430 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250154166-A1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD. (CN) | 2025-05-15 | — | — | US | disclosed |
| EP-3632914-B1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN AKEYLINK BIOTECHNOLOGY CO LTD (CN) | 2022-08-31 | — | — | EP | disclosed |
| US-20200197409-A1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | FUJIAN COSUNTER PHARMACEUTICAL CO., LTD. (CN) | 2020-06-25 | — | — | US | disclosed |
| EP-3632914-A1 | HEPATITIS B VIRUS SURFACE ANTIGEN INHIBITOR | Fujian Cosunter Pharmaceutical Co., Ltd. (CN) | 2020-04-08 | — | — | EP | disclosed |